Machine Learning for Drug Discovery
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $260M
Founded date: 2019
Investors 8
| Date | Name | Website |
| - | ACE & ... | aceandcomp... |
| - | HOF Capita... | hofcapital... |
| 18.02.2022 | Breyer Cap... | breyercapi... |
| - | Y Combinat... | ycombinato... |
| 03.06.2020 | HOF Capita... | hofvc.com |
| 20.03.2024 | Lifeforce ... | lifeforcec... |
| 27.01.2022 | I2BF Globa... | i2bf.com |
| 02.11.2020 | Pioneer Fu... | pioneerfun... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.01.2022 | - | $260M | - |
Mentions in press and media 8
| Date | Title | Description |
| 30.06.2026 | Verge Labs представила «виртуальную биопсию» для разработки лекарств от болезней мозга | Создание лекарств от заболеваний мозга остается одной из самых сложных и рискованных задач в медицине. Компания Verge Labs пытается ускорить этот процесс с помощью искусственного интеллекта, который анализирует данные о человеческом мозге и... |
| 11.01.2022 | PostEra announces $260M multi-target strategic AI Lab collaboration with Pfizer | BOSTON, Jan. 11, 2022 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced the expansion of the company's existing strategic collaboration with Pfizer. The expande... |
| 11.01.2022 | PostEra Secures $24M, Forms $260M AI Lab Collaboration with Pfizer | What You Should Know: – PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients. – PostEra ... |
| 11.01.2022 | PostEra Closes $24M in New Financing to Advance Drug Discovery | BOSTON, Jan. 11, 2022 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patien... |
| 11.01.2022 | PostEra Closes $24 Million in New Financing to Advance Drug Discovery | PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced $24 Million in equity financing to accelerate medicinal chemistry and bring new cures to patients. PostEra will use the proceeds to ... |
| 20.05.2021 | PostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19 | PostEra, a biotechnology company specialising in machine learning for drug discovery, today announced that it has received a grant of £100,000 from the independent medical charity LifeArc to support an international effort to rapidly develo... |
| 26.04.2020 | Top 25 Machine Learning Startups To Watch In 2020 | istock |
| 17.03.2020 | All the companies from Y Combinator’s W20 Demo Day, Part III: Hardware, Robots, AI and Developer Tools | Y Combinator’s Demo Day was a bit different this time around. As concerns grew over the spread of COVID-19, Y Combinator shifted the event format away from the two-day gathering in San Francisco we’ve gotten used to, instead opting to have ... |